跳至主要内容
临床试验/NCT05396287
NCT05396287进行中(未招募)不适用

The Impact of Cerebral Anatomical Variations on Cerebrovascular Reactivity

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年7月19日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
80
试验地点
1
主要终点
Cerebral Vascular Reactivity to Hypercapnia

研究概览

简要总结

Brain blood flow regulation will be measured in response to environmental changes using MRI.

详细描述

Global brain blood flow decreases with advancing age; however, some adults have accelerated declines in brain blood flow, placing them at a greater risk of cognitive impairment. Similarly, brain reactivity to increased levels of carbon dioxide decreases with age, with a greater decline in adults with vascular risk factors and is impaired in early Alzheimer's disease. Preclinical models suggest that reduced brain blood flow, results in low levels of oxygen regionally. Currently, there are a lack of human studies that investigate the cause or consequence of altered blood flow regulation in the brain.

The research aims are:

  1. Determine the impact of vertebral artery hypoplasia (VAH) on brain reactivity to increased levels of carbon dioxide.
  2. Determine the impact of VAH on the brain blood flow response to acute low levels of oxygen.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
55 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI ≤38.5 kg/m2
  • Nonsmoker
  • Female subjects: postmenopausal
  • Currently enrolled in the Wisconsin Alzheimer's Disease Research Clinical Core

排除标准

  • Diagnosis of mild cognitive impairment or Alzheimer's disease
  • Uncontrolled hypertension
  • History or evidence of hepatic disease, hematological disease, or peripheral vascular disease
  • Severe kidney injury requiring hemodialysis
  • Cardiovascular disease including: severe congestive heart failure, coronary artery disease, ischemic heart disease (stents, coronary artery bypass grafts) and tachycardia
  • History of clinically significant ischemic or hemorrhagic stroke, or significant cerebrovascular disease
  • History of HIV/AIDS
  • Severe untreated obstructive sleep apnea
  • History of diabetes with HbA1c greater than 9.5%
  • Major neurologic disorders other than dementia (e.g., multiple sclerosis, amyotrophic lateral sclerosis, brain surgery, etc.)
  • Current or recent (<1 year) major psychiatric condition (Axis I) or addictive disorders
  • Contraindications to MRI

结局指标

主要结局

Cerebral Vascular Reactivity to Hypercapnia

时间窗: One study visit, up to 120 minutes in the MRI

The change in brain blood flow using MRI will be measured in response to a hypercapnic breathing test. The participants cerebral vascular reactivity to hypercapnia will be compared between the controls (without VAH) and those with VAH.

Cerebral Blood Flow Response to Hypoxia

时间窗: One study visit, up to 120 minutes in the MRI

The change in brain blood flow using MRI will be measured in response to a hypoxic breathing test. The participants cerebral blood flow response to hypoxia will be compared between the controls (without VAH) and those with VAH.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验